Biotech/Pharma
ParcelBio
Elevated mRNA for transformative medicines Engineered to reach therapeutic thresholds that existing mRNA can't.
CORE INFO
$13M
Total FundingSeed
RoundWhy existing mRNA falls short. mRNA has already changed medicine. But the next generation of mRNA medicines – therapies that reprogram the immune system, kill tumors, and replace missing proteins – require a step-change in potency and durability. Conventional mRNA can't get there. APEXm™ can